Leptin treatment: Facts and expectations

Gilberto Pas-Filho, C Mastronardi, Julio Licinio

Research output: Contribution to journalArticlepeer-review

159 Citations (Scopus)


Leptin has key roles in the regulation of energy balance, body weight, metabolism, and endocrine function. Leptin levels are undetectable or very low in patients with lipodystrophy, hypothalamic amenorrhea, and congenital leptin deficiency (CLD) due to mutations in the leptin gene. For these patients, leptin replacement therapy with metreleptin (a recombinant leptin analog) has improved or normalized most of their phenotypes, including normalization of endocrine axes, decrease in insulin resistance, and improvement of lipid profile and hepatic steatosis. Remarkable weight loss has been observed in patients with CLD. Due to its effects, leptin therapy has also been evaluated in conditions where leptin levels are normal or high, such as common obesity, diabetes (types 1 and 2), and Rabson-Mendenhall syndrome. A better understanding of the physiological roles of leptin may lead to the development of leptin-based therapies for other prevalent disorders such as obesity-associated nonalcoholic fatty liver disease, depression and dementia.

Original languageEnglish
Pages (from-to)146-156
Number of pages11
JournalMetabolism-Clinical and Experimental
Issue number1
Publication statusPublished - 1 Jan 2015


  • Congenital leptin deficiency
  • Leptin
  • Metreleptin
  • Myalept
  • Obesity


Dive into the research topics of 'Leptin treatment: Facts and expectations'. Together they form a unique fingerprint.

Cite this